1. Introduction {#sec1}
===============

With an increasing incidence and economic burden \[[@B1], [@B2]\], type 2 diabetes mellitus (DM) has been a significant public health concern worldwide. The global prevalence (age standardized) of DM has risen to 8.5% in the adult population in 2014 \[[@B3]\] and has grown fast in low- and middle-income countries over the past decade. Unfortunately, China is one of the countries facing serious challenges, with a prevalence of DM of 10.4% (World Health Organization, WHO 1999 criteria) in the population aged 18 and above in 2013 \[[@B4]\]. However, only 36.5% of the patients in China were aware of their diabetes condition \[[@B4]\]. There is an urgent need to apply valid measures for the screening of DM.

The other major issue is the detection of prediabetes (preDM), including impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG). PreDM is a transition between normal glucose tolerance and diabetes, and it has been proved to be a critical high-risk factor of DM. The prevalence of preDM had reached 35.7% (American Diabetic Association, ADA 2003 criteria) in China in 2013 \[[@B4]\], which means that there may be a large number of patients with DM in the next few decades. However, the same as above, most of the individuals did not realize that they were at high risk of developing DM \[[@B5]\].

The previous studies demonstrate the significant roles of lifestyle intervention and early treatment in the prevention of DM \[[@B6]--[@B11]\], which highlight the importance of detecting DM and preDM at an early stage. However, the oral glucose tolerance test (OGTT) is complicated to implement, time-consuming, costly, and difficult to accept by most residents. In that, researchers have developed several DM risk assessments through nonlaboratory indicators for the rapid screening of undiagnosed DM in different populations \[[@B12]--[@B21]\]. There were also several DM risk measures developed for the Chinese population \[[@B22]--[@B25]\]. However, these measures were developed based on local conditions, and most of them did not consider issues such as gender differences. To provide a unified DM risk measurement, researchers developed a new assessment in 2013, the New Chinese Diabetes Risk Score (NCDRS) \[[@B26]\]. NCDRS is a DM risk assessment that includes age (years), gender, waist circumference (WC: cm), body mass index (BMI: kg/m^2^), systolic blood pressure (SBP: mmHg), and family history of DM \[[@B26]\]. It has been recommended as a unified tool for screening of undiagnosed DM in China \[[@B27]\]. However, two questions remain about the performance of NCDRS. First, only a few studies have reported on the efficacy of NCDRS in the detection of DM. Of these studies, most have suffered from small sample sizes and some were even conducted in a single clinic; others focused only on older adults \[[@B28], [@B29]\]. As we know, China is a multiethnic country with different economic levels and living habits. Research on the applicability of NCDRS in screening DM in different regions of China would be necessary. Second, to the best of our knowledge, no studies have evaluated the performance of NCDRS in screening preDM in a large sample of community residents in China. The efficacy of NCDRS in the detection of preDM requires further research.

Our study is aimed at filling the gap by evaluating the efficacy of NCDRS in the detection of undiagnosed DM and preDM among community residents in eastern China. In the present study, we conducted a community-based cross-sectional investigation in Jiangsu Province, eastern China. Urban and rural residents aged between 18 and 65 years old were investigated. This study will enhance our understanding of the performance of NCDRS in screening undiagnosed DM in the Chinese population and shed new light on its efficacy in detecting preDM.

2. Materials and Methods {#sec2}
========================

2.1. Study Design and Population {#sec2.1}
--------------------------------

A community-based cross-sectional study was conducted in Jiangsu Province of China from March to June 2016. The study population and procedures have been reported previously \[[@B30]\]. In brief, a four-stage stratified sampling method was used to select a representative sample of the general population in Jiangsu. A total of 8119 urban and rural residents aged between 18 and 65 years old were randomly selected from six districts or counties for the questionnaire survey, anthropometric measurement, and 2-hour oral glucose tolerance test (2 h-OGTT). People who have been diagnosed with diabetes, pregnancy, and severe mental disorders were excluded. Residents who failed to complete the questionnaire survey, anthropometric measurement, or blood specimen collection were excluded from data analysis. Finally, a total of 7675 residents were included in the analysis.

2.2. New Chinese Diabetes Risk Score (NCDRS) {#sec2.2}
--------------------------------------------

The scores of NCDRS are shown in [Table 1](#tab1){ref-type="table"}. The total score ranged from 0 to 51, and the recommended optimal cut-off point for undiagnosed DM was 25 \[[@B26]\].

2.3. Data Collection {#sec2.3}
--------------------

The study was conducted in local township health centers by trained research staff. A standard questionnaire was used, including personal information such as sociodemographic characteristics and family history of DM. Anthropometric measurements were taken by trained observers, included body weight, height, waist circumference, and blood pressure.

2.4. Laboratory Measurements {#sec2.4}
----------------------------

A 5 mL blood specimen was obtained for fasting plasma glucose (FPG) measurement after at least 8 hours of fasting. The other 5 mL blood specimen was obtained for 2-hour plasma glucose (2 h PG) measurement after a 75 g anhydrous glucose load for two hours. As the six districts or counties were geographically distant, the laboratory tests of plasma glucose (PG) were carried out by local people\'s hospitals at the county or the center for disease control and prevention. The instruments and methods used to measure PG have been reported previously \[[@B30]\].

2.5. DM and PreDM Definition {#sec2.5}
----------------------------

According to the 1999 World Health Organization (WHO) criteria, DM was defined as FPG ≥ 7.0 mmol/L or 2 h PG ≥ 11.1 mmol/L. PreDM was defined as 6.1 mmol/L ≤ FPG \< 7.0 mmol/L or 7.8 mmol/L ≤ 2 h PG \< 11.1 mmol/L. Normal glucose tolerance was defined as FPG \< 6.1 mmol/L and 2 h PG \< 7.8 mmol/L.

2.6. Ethical Consideration {#sec2.6}
--------------------------

This study was approved by the Ethics Review Committee of Jiangsu Provincial Center for Disease Control and Prevention (No. JSJK2016-B003-03). Informed consent was obtained from each participant.

2.7. Statistical Analysis {#sec2.7}
-------------------------

Continuous and categorical variables were described by mean ± standard deviation (*X* ± SD) and percentage (%). According to different glucose metabolism levels, the characteristics of each group were described. Comparisons among the groups were made with one-way ANOVA for continuous variables and Chi-square test for proportions. Sensitivity, specificity, Youden index, positive predictive value, and negative predictive value were calculated for each NCDRS value from 25 to 32 for screening undiagnosed DM, preDM, or both of them. The optimal cut-off point was determined by the highest Youden index. The receiver operating characteristic (ROC) curves by gender and age groups were used to present the performance of NCDRS in screening both undiagnosed DM and preDM. The area under the curve (AUC) was used to evaluate the screening effect of NCDRS. All statistical analyses were performed in SPSS 17.0 and MedCalc18.11.3.

3. Results {#sec3}
==========

The characteristics of the participants were presented in [Table 2](#tab2){ref-type="table"}. The average age of the participants was 43.8 ± 11.9 years old, and 56.0% were female. Of the participants, 41.7% had a middle school education, and 39.0% were farmers. 16.8% of the participants reported that they had a family history of diabetes. Among all participants, the average BMI, WC, SBP, DBP, FPG, and 2 h PG were 25.1 ± 4.0 kg/m^2^, 83.5 ± 10.4 cm, 128.2 ± 18.8 mmHg, 79.2 ± 11.7 mmHg, 5.5 ± 1.0 mmol/L, and 6.6 ± 2.5 mmol/L, respectively. The average NCDRS score was 24.1 ± 9.3, and 52.1% of the participants reported a high-risk score (NCDRS ≥ 25). The detection rates of undiagnosed DM and preDM were 6.5% (95% CI: 5.96% to 7.07%) and 16.7% (95% CI: 15.91% to 17.58%). The detection rates for DM and preDM in the high-risk group (NCDRS ≥ 25) were 10.6% and 23.6%, while the detection rates in the low-risk group (NCDRS \< 25) were 2.1% and 9.3%. By using the LSD method, the NCDRS scores of DM were higher than the scores of preDM (*P* \< 0.001), and the scores of preDM were higher than the scores of normal glucose tolerance residents (*P* \< 0.001). There was a certain relationship between the NCDRS scores and the glucose metabolism levels.

As shown in [Table 3](#tab3){ref-type="table"}, the optimal cut-off point for the detection of undiagnosed DM was 31 for men (sensitivity = 65.2%, specificity = 69.0%) and 27 for women (sensitivity = 76.2%, specificity = 63.5%). For preDM, the optimal cut-off point was 29 for men (sensitivity = 61.1%, specificity = 64.7%) and 26 for women (sensitivity = 65.7%, specificity = 64.5%). When screening both undiagnosed DM and preDM, the best cut-off point was 27 for men (sensitivity = 73.5%, specificity = 55.6%) and 26 for women (sensitivity = 69.3%, specificity = 64.5%). In the total sample, the optimal cut-off point for screening undiagnosed DM was 27 (sensitivity = 78.0%, specificity = 57.7%, Youden index = 0.357), same as for the detection of preDM (sensitivity = 66.0%, specificity = 62.9%, Youden index = 0.289). At the cut-off point of 25 recommended by NCDRS, sensitivity, specificity, and Youden index of detecting undiagnosed DM were 84.8%, 50.1%, and 0.349, respectively. The PPV of NCDRS was 11.4% for DM and 20.8% for preDM.

The areas under the ROC curves (AUCs) for identifying undiagnosed DM were 0.731 in men and 0.761 in women (*P* = 0.139). The AUC of the ≥45 age group was smaller than that of the other age groups (all *P* \< 0.05) (see Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}). The AUCs for identifying preDM were 0.683 in men and 0.698 in women (*P* = 0.325). There was a statistically significant difference in the AUCs between the 45-54 age group and the ≤44 age group (all *P* \< 0.05) (see Figures [1(c)](#fig1){ref-type="fig"} and [1(d)](#fig1){ref-type="fig"}). The AUCs for identifying undiagnosed DM and preDM were 0.749 (95% CI: 0.739\~0.759) and 0.694 (95% CI: 0.683\~0.705). The AUC for identifying both undiagnosed DM and preDM was 0.718 (95% CI: 0.708\~0.728) in the total sample.

4. Discussion {#sec4}
=============

One of the aims of our study was to evaluate the performance of NCDRS in screening undiagnosed DM among community residents in eastern China. As we expected, NCDRS showed excellent validity in detecting undiagnosed DM. The AUC for identifying undiagnosed DM was 0.749 in this study, which was similar to 0.748 reported in the China National Diabetes and Metabolic Disorders Study \[[@B26]\]. However, the optimal cut-off point for undiagnosed DM in this study was 27, two points higher than the recommended cut-off point of 25 in the national survey above. In previous studies \[[@B28], [@B29]\], the best cut-off point was 33 in the population aged over 60 years and 20 in the hospital physical examination group. The possible cause for these differences may be attributed to the differences in age, regions, and other demographic characteristics among these findings. It indicates that, as we mentioned above, studies on the applicability of NCDRS in screening DM in different regions and populations of China is necessary. We found that, when using for the screening of undiagnosed DM, the sensitivity and specificity of NCDRS at the optimal cut-off point of 27 in this study were 78.0% and 57.7%; while at the recommended cut-off point of 25, the sensitivity and specificity were 84.8% and 50.1%. It demonstrates that, when using the cut-off value of 27 in community residents in eastern China, the sensitivity may decrease. Still, the specificity will improve, which could reduce the proportion of individuals who are misjudged as DM. Taken together, these findings suggest that a cut-off score of 27 is more applicable if we seek to maximize the effects of screening. However, given the severe consequences of missed diagnosis, a cut-off point of 25, so as to improve the sensitivity of detection, is also recommended in practice.

Moreover, NCDRS had a low PPV (11.4%) for DM in our study, which was similar to 11.8% reported in the national survey above \[[@B26]\]. As we know, more benefits of further diagnosis for individuals who were screening positive could be obtained as PPV increased. However, the PPV was closely related to the prevalence of the target disease in the tested population. When sensitivity and specificity were constant, PPV increased with the risen prevalence of the target disease. One previous study reported that the sensitivity and specificity of NCDRS were 70.5% and 53.0% in Chinese adults aged 45-70 with an undiagnosed DM prevalence of 15.3% \[[@B25]\], resulting in a PPV of 21.3%. It indicates that using NCDRS in a population with a higher prevalence of undiagnosed DM will result in higher benefits. Therefore, it is better to use NCDRS for screening the high-risk group of DM in the future.

To the best of our knowledge, this study is the first to evaluate the efficacy of NCDRS in screening preDM in a large sample of representative community residents in China. We found that the AUC of NCDRS in screening preDM was 0.694, indicating that NCDRS also performs well in the detection of preDM. Compared with the cut-off points for the detection of undiagnosed DM, the optimal cut-off scores for the detection of preDM were two points lower in men and one point lower in women. However, in the total sample, the optimal cut-off point for screening preDM was 27, which shared the same value with screening undiagnosed DM. It is an interesting finding that NCDRS may differ from other DM risk assessments. For example, in both the ADA scores and CDC scores, the cut-off points for preDM were one point lower than the points for DM \[[@B31]\]. It may be due to the fact that preDM shares common risk factors with DM in eastern China \[[@B32], [@B33]\]. Nevertheless, using the same cut-off point for the detection of DM and preDM makes NCDRS more convenient and applicable for practice.

There was no statistically significant difference in the AUC of NCDRS in detecting undiagnosed DM and preDM between men and women. However, the AUC showed statistically significant differences in identifying undiagnosed DM and preDM among different age groups. The performance of NCDRS was more effective in the ≤44 age group compared with the ≥45 age group in both DM and preDM. The previous study has shown that the DM risk assessments could neither provide efficient screening of DM, nor could they identify individuals with elevated blood glucose levels in an older population (≥55 years old) \[[@B34]\]. That is, like other assessments, NCDRS may be more applicable in a younger population. It means that NCDRS could play a significant role in early detection, early diagnosis, and early treatment, in which a higher return would be expected.

Several limitations to the current study need to be acknowledged. First, the tests of plasma glucose were conducted in different laboratories, which may result in slight differences in the value of plasma glucose. However, all of the tests were carried out by the local public hospital or the CDC. All laboratories of these institutes meet the requirements of the Administrative Measures for Clinical Laboratory of Medical Institutions. The instruments and reagents were also calibrated. Second, although we have taken efforts to collect samples from both urban and rural areas, the samples were only from one province in eastern China, which raises concerns about the possible selection bias. Further research in different regions is needed. Third, due to the nature of the cross-sectional study, we were unable to evaluate the performance of NCDRS in predicting DM and preDM events. We will try to conduct a follow-up study and assess the predictive validity of NCDRS further.

5. Conclusions {#sec5}
==============

In conclusion, this study is the first to assess the efficacy of NCDRS in the screening of undiagnosed DM and preDM in a large sample of community residents in eastern China. The findings suggest that NCDRS performs well in screening both undiagnosed DM and preDM. Our study not only supports the excellent efficacy of NCDRS in the detection of undiagnosed DM but also highlights its potential usefulness in detecting preDM.
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###### 

The scores of NCDRS.

  Indicators       Score   Indicators                               Score
  ---------------- ------- ---------------------------------------- -------
  Age (years)^a^           Waist circumference (cm)                 
   20-24           0       \<75 (men) or \<70 (women)               0
   25-34           4       75-79.9 (men) or 70-74.9 (women)         3
   35-39           8       80-84.9 (men) or 75-79.9 (women)         5
   40-44           11      85-89.9 (men) or 80-84.9 (women)         7
   45-49           12      90-94.9 (men) or 85-89.9 (women)         8
   50-54           13      ≥95 (men) or ≥90 (women)                 10
   55-59           15      Systolic blood pressure (mmHg)           
   60-64           16      \<110                                    0
   65-84           18      110-119                                  1
  BMI (kg/m^2^)            120-129                                  3
   \<22            0       130-139                                  6
   22-23.9         1       140-149                                  7
   24-29.9         3       150-159                                  8
   ≥30             5       ≥160                                     10
  Sex                      Family history of diabetes, yes vs. no   
   Women           0       No                                       0
   Men             2       Yes                                      6

Note: ^a^participants aged 18 and 19 scored 0 for "Age" in the present study.

###### 

Characteristics of the participants included in the study, by glucose metabolism levels.

                                   Overall (*n* = 7675)   Normal glucose tolerance (*n* = 5890)   PreDM (*n* = 1285)   DM (*n* = 500)   *P* value
  -------------------------------- ---------------------- --------------------------------------- -------------------- ---------------- ------------
  Gender                                                                                                                                
   Male                            3374 (44.0)            2486 (42.2)                             632 (49.2)           256 (51.2)       \<0.001^b^
   Female                          4301 (56.0)            3404 (57.8)                             653 (50.8)           244 (48.8)       
  Age (years)                      43.8 ± 11.9            42.3 ± 11.9                             48.3 ± 10.6          49.4 ± 10.0      \<0.001^a^
  Age group                                                                                                                             
   18-24                           385 (5.0)              354 (6.0)                               24 (1.9)             7 (1.4)          \<0.001^b^
   25-34                           1620 (21.1)            1440 (24.4)                             136 (10.6)           44 (8.8)         
   35-44                           1603 (20.9)            1284 (21.8)                             238 (18.5)           81 (16.2)        
   45-54                           2552 (33.3)            1844 (31.3)                             504 (39.2)           204 (40.8)       
   55-65                           1515 (19.7)            968 (16.4)                              383 (29.8)           164 (32.8)       
  Education level                                                                                                                       
   Below primary school            784 (10.2)             520 (8.8)                               206 (16.0)           58 (11.6)        \<0.001^b^
   Primary school                  1332 (17.4)            951 (16.1)                              280 (21.8)           101 (20.2)       
   Middle school                   3203 (41.7)            2462 (41.8)                             509 (39.6)           232 (46.4)       
   High school                     1630 (21.2)            1323 (22.5)                             218 (17.0)           89 (17.8)        
   College and above               726 (9.5)              634 (10.8)                              72 (5.6)             20 (4.0)         
  Occupation                                                                                                                            
   Public institution officer^c^   1061 (13.8)            854 (14.5)                              162 (12.6)           45 (9.0)         \<0.001^b^
   Company employee                2231 (29.1)            1801 (30.6)                             308 (24.0)           122 (24.4)       
   Farmer                          2995 (39.0)            2093 (35.5)                             642 (50.0)           260 (52.0)       
   Other                           1388 (18.1)            1142 (19.4)                             173 (13.5)           73 (14.6)        
  Family history of diabetes                                                                                                            
   Yes                             1290 (16.8)            920 (15.6)                              248 (19.3)           122 (24.4)       \<0.001^b^
   No                              6385 (83.2)            4970 (84.4)                             1037 (80.7)          378 (75.6)       
  BMI (kg/m^2^)                    25.1 ± 4.0             24.7 ± 3.9                              26.3 ± 3.6           27.4 ± 3.9       \<0.001^a^
  WC (cm)                          83.5 ± 10.4            82.2 ± 10.3                             86.8 ± 9.7           90.3 ± 10.0      \<0.001^a^
  SBP (mmHg)                       128.2 ± 18.8           125.7 ± 18.0                            134.9 ± 18.9         140.4 ± 18.1     \<0.001^a^
  DBP (mmHg)                       79.2 ± 11.7            77.8 ± 11.4                             82.8 ± 11.7          85.2 ± 10.9      \<0.001^a^
  FPG (mmol/L)                     5.5 ± 1.0              5.2 ± 0.4                               5.9 ± 0.6            7.8 ± 2.1        \<0.001^a^
  2 h PG (mmol/L)                  6.6 ± 2.5              5.6 ± 1.0                               8.2 ± 1.5            13.4 ± 4.1       \<0.001^a^
  NCDRS value                      24.1 ± 9.3             22.5 ± 9.2                              28.7 ± 7.4           31.5 ± 6.7       \<0.001^a^
  NCDRS group                                                                                                                           
   Low-risk (NCDRS \< 25)          3673 (47.9)            3255 (55.3)                             342 (26.6)           76 (15.2)        \<0.001^b^
   High-risk (NCDRS ≥ 25)          4002 (52.1)            2635 (44.7)                             943 (73.4)           424 (84.8)       

Note: data are reported as mean ± standard deviation or frequency (percent (%)); BMI=body mass index; WC=waist circumference; SBP=systolic blood pressure; DBP=diastolic blood pressure; FPG=fasting plasma glucose; 2 h PG=2 hour plasma glucose. ^a^The *P* value of one-way ANOVA. ^b^The *P* value of the Chi-square test. ^c^Public institution officers include government officers, teachers, medical staffs, and other public institution officers.

###### 

Sensitivity, specificity, Youden index, positive predictive value (PPV), and negative predictive value (NPV) of NCDRS cut-off points in identifying undiagnosed DM and preDM in men and women in the study.

  Cut-off point   Men        Women      Total                                                                                                                                  
  --------------- ---------- ---------- ----------- ---------- ---------- ---------- ---------- ----------- ---------- ---------- ---------- ---------- ----------- ---------- ----------
  DM^a^                                                                                                                                                                        
  25              86.7       42.6       0.293       11.0       97.5       82.8       56.0       0.387       10.2       98.2       84.8       50.1       0.349       10.6       97.9
  26              83.6       46.3       0.299       11.3       97.2       79.1       59.6       0.387       10.6       97.9       81.4       53.9       0.353       10.9       97.7
  27              79.7       50.2       0.299       11.6       96.8       **76.2**   **63.5**   **0.397**   **11.2**   **97.8**   **78.0**   **57.7**   **0.357**   **11.4**   **97.4**
  28              75.4       54.8       0.302       12.1       96.4       71.3       67.1       0.384       11.5       97.5       73.4       61.7       0.351       11.8       97.1
  29              72.3       59.5       0.318       12.8       96.3       67.2       70.7       0.379       12.1       97.3       69.8       65.8       0.356       12.5       96.9
  30              68.8       64.3       0.330       13.6       96.2       60.7       74.7       0.354       12.6       96.9       64.8       70.2       0.350       13.2       96.6
  31              **65.2**   **69.0**   **0.342**   **14.7**   **96.0**   55.3       78.3       0.336       13.3       96.7       60.4       74.3       0.347       14.1       96.4
  32              58.2       73.8       0.320       15.4       95.6       50.0       82.1       0.321       14.4       96.5       54.2       78.5       0.327       14.9       96.1
  PreDM^b^                                                                                                                                                                     
  25              77.5       47.7       0.252       27.4       89.3       69.4       60.8       0.301       25.4       91.2       73.4       55.3       0.286       26.4       90.5
  26              73.9       51.5       0.254       27.9       88.6       **65.7**   **64.5**   **0.302**   **26.2**   **90.7**   69.7       59         0.287       27.1       89.9
  27              71.0       55.6       0.267       28.9       88.3       61.1       68.2       0.293       26.9       90.1       **66.0**   **62.9**   **0.289**   **28.0**   **89.5**
  28              65.7       60.0       0.257       29.5       87.3       56.5       71.6       0.281       27.6       89.6       61.0       66.7       0.277       28.6       88.7
  29              **61.1**   **64.7**   **0.258**   **30.6**   **86.7**   50.4       74.7       0.251       27.7       88.7       55.6       70.5       0.262       29.2       87.9
  30              55.9       69.4       0.252       31.7       86.1       44.6       78.4       0.230       28.4       88.1       50.1       74.6       0.247       30.1       87.3
  31              50.0       73.8       0.238       32.7       85.3       38.1       81.5       0.196       28.3       87.3       44.0       78.2       0.222       30.6       86.5
  32              42.6       77.9       0.205       32.9       84.2       33.1       85.0       0.180       29.7       86.9       37.7       82.0       0.197       31.4       85.8
  PreDM/DM^c^                                                                                                                                                                  
  25              80.2       47.7       0.278       35.4       87.1       73.0       60.8       0.338       32.9       89.5       76.6       55.3       0.318       34.2       88.6
  26              76.7       51.5       0.282       36.1       86.1       **69.3**   **64.5**   **0.339**   **34.0**   **88.9**   73.0       59.0       0.320       35.1       87.8
  27              **73.5**   **55.6**   **0.292**   **37.2**   **85.5**   65.2       68.2       0.334       35.1       88.2       **69.4**   **62.9**   **0.322**   **36.2**   **87.1**
  28              68.5       60.0       0.285       38.0       84.2       60.5       71.6       0.321       36.0       87.3       64.5       66.7       0.312       37.0       86.1
  29              64.3       64.7       0.290       39.4       83.5       55.0       74.7       0.297       36.4       86.3       59.6       70.5       0.301       38.0       85.2
  30              59.6       69.4       0.290       41.0       82.8       48.9       78.4       0.273       37.4       85.4       54.2       74.6       0.288       39.3       84.3
  31              54.4       73.8       0.282       42.6       81.9       42.8       81.5       0.243       37.8       84.4       48.6       78.2       0.268       40.3       83.4
  32              47.1       77.9       0.250       43.2       80.5       37.7       85.0       0.226       39.8       83.8       42.4       82.0       0.244       41.6       82.4

Note: DM=diabetes mellitus; preDM=prediabetes. ^a^Detecting undiagnosed diabetes among all participants. ^b^Detecting prediabetes among participants excluding undiagnosed diabetes. ^c^Detecting undiagnosed diabetes and prediabetes among all participants.

[^1]: Academic Editor: Suat Simsek
